Medical News Today
February 22, 2022
Dr. Eric L. Simpson, MCR, a professor of dermatology and director of clinical research in the Department of Dermatology at Oregon Health & Science University in Portland, explains in a National Eczema Association webinar:
“JAK inhibitors all improve itch rapidly within days, the skin rash, and the quality of life. For some of these severe patients, it can be extremely helpful. [However,] if they have a history of blood clots, history of cancer, or a history of severe infection needing hospitalization, I may not use a JAK inhibitor.”